Abstract: The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

Abstract: The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

Abstract: Methods comprising steps for processing data for a customer-agent interaction are disclosed, as well as systems configured to perform such steps. These steps may comprise retrieving a web form comprising one or more elements, from a web server, using a first device; displaying the web form to the agent via a browser running on the first device; detecting, by the first device, an interaction of the agent with a first element in the web form; modifying the web form using a program running in the browser; generating a submission from the web form; and transmitting the submission to a service provider.

Abstract: Methods comprising steps for processing data for a customer-agent interaction are disclosed, as well as systems configured to perform such steps. These steps may comprise retrieving a web form comprising one or more elements, from a web server, using a first device; displaying the web form to the agent via a browser running on the first device; detecting, by the first device, an interaction of the agent with a first element in the web form; modifying the web form using a program running in the browser; generating a submission from the web form; and transmitting the submission to a service provider.

Abstract: The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.

Abstract: A computer-implemented method for correlating payment service submissions and data captured from a call stream is described herein. The method comprises receiving data captured from a call stream by a data capture device; receiving a payment service submission comprising an identifier; determining an association between the identifier and the call stream; and replacing the identifier in the payment service submission with the data captured from the call stream associated with the identifier.

Abstract: The invention relates to a method of producing a food or beverage product, comprising the steps of: providing an ingredient composition comprising micellar caseins, whey protein and plant protein having a pH of 5.9-7.1, preferably 6.2-6.8, and having a concentration of 1 to 15 wt. % of total proteins, and wherein the composition has a micellar casein to whey protein ratio of, 90/10 to 60/40 and a micellar caseins and whey protein to plant protein ratio of 80/20 to 20/80, adding divalent cations to provide a concentration of 2.0-10 mM free divalent cations in the ingredient composition and subsequently heat treating the ingredient composition to form agglomerated proteins comprising micellar casein, whey protein and plant proteins, the agglomerates having a size of 5 to 50 microns as measured by D(4,3) mean diameter as measured by laser diffraction. The invention also relates to a product obtained by this method.

Abstract: The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

Abstract: The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.

Abstract: The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

Abstract: The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.

Abstract: The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.

Abstract: The invention relates to a method of producing a food or beverage product, comprising the steps of: providing an ingredient composition comprising micellar caseins, whey protein and plant protein having a pH of 5.9-7.1, preferably 6.2-6.8, and having a concentration of 1 to 15 wt. % of total proteins, and wherein the composition has a micellar casein to whey protein ratio of, 90/10 to 60/40 and a micellar caseins and whey protein to plant protein ratio of 80/20 to 20/80, adding divalent cations to provide a concentration of 2.0-10 mM free divalent cations in the ingredient composition and subsequently heat treating the ingredient composition to form agglomerated proteins comprising micellar casein, whey protein and plant proteins, the agglomerates having a size of 5 to 50 microns as measured by D(4,3) mean diameter as measured by laser diffraction. The invention also relates to a product obtained by this method.

Abstract: The present invention relates to a telephone call processing system and a method of processing telephone calls, and in particular to systems and methods that facilitate secure transmission and accurate identification of sensitive information spoken during a call between a caller and an agent such that the agent does not have access to the sensitive information. The methods of the present invention involve outputting scrambled, out-of-sequence and/or partitioned sub-sets of a spoken voice stream to one or more recognition agents, which identify elements of the sensitive information and return the identified elements to a call processor for un-scrambling, re-ordering and/or re-assembly by the call processor to produce the identified sensitive information.

Abstract: The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.

Abstract: The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.

Abstract: The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.

Abstract: The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.

Abstract: The present disclosure relates generally to methods and compositions for preventing or arresting cell death and/or inflammation.

Abstract: The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.